Quantification of Regulatory T Cells in Septic Patients by Real-Time PCR-Based Methylation Assay and Flow Cytometry

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Tatura, Roman ^a   Zeschnigk, Michael ^a   Adamzik, Michael ^a   Probst Kepper, Michael ^b   Buer, Jan ^a   Kehrmann, Jan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; DNA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; HUMAN; INTERMETHOD COMPARISON; MALE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION BASED METHYLATION ASSAY; REGULATORY T LYMPHOCYTE; SEPSIS; VALIDATION STUDY;

ADULT; AGED; ANTIGENS, CD4; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84870260524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049962     Document Type: Article

References (38)

1. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344-353. 00003246-200602000-00010 [pii].
2. Brunkhorst FM, (2006) [Epidemiology, economy and practice - results of the German study on prevalence by the competence network sepsis (SepNet)]. Anasthesiol Intensivmed Notfallmed Schmerzther 41: 43-44. 10.1055/s-2005-921227 [doi].
3. Rittirsch D, Flierl MA, Ward PA, (2008) Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776-787. nri2402 [pii];10.1038/nri2402 [doi].
4. Yende S, Angus DC, (2007) Long-term outcomes from sepsis. Curr Infect Dis Rep 9: 382-386.
5. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, et al. (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3: 678-681.
6. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, et al. (2009) Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35: 678-686. 10.1007/s00134-008-1337-8 [doi].
7. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, et al. (2003) Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31: 2068-2071. 10.1097/01.CCM.0000069345.78884.0F [doi].
8. Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, et al. (2010) The relationship between CD4+ CD25+ CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14: R19. cc8876 [pii];10.1186/cc8876 [doi].
9. Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, et al. (2006) Increased natural CD4+ CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177: 7943-7949. 177/11/7943 [pii].
10. Venet F, Chung CS, Monneret G, Huang X, Horner B, et al. (2008) Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83: 523-535. jlb.0607371 [pii];10.1189/jlb.0607371 [doi].
11. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, et al. (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103: 6659-6664. 0509484103 [pii];10.1073/pnas.0509484103 [doi].
12. Ziegler SF, (2007) FOXP3: not just for regulatory T cells anymore. Eur J Immunol 37: 21-23. 10.1002/eji.200636929 [doi].
13. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, et al. (2009) Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 69: 599-608. 69/2/599 [pii];10.1158/0008-5472.CAN-08-2361 [doi].
14. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, et al. (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37: 2378-2389. 10.1002/eji.200737594 [doi].
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136: e28.
16. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS, (1991) 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19: 4008.
17. Zeschnigk M, Bohringer S, Price EA, Onadim Z, Masshofer L, et al. (2004) A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. Nucleic Acids Res 32: e125. 10.1093/nar/gnh122 [doi];32/16/e125 [pii].
18. Probst-Kepper M, Geffers R, Kroger A, Viegas N, Erck C, et al. (2009) GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 13: 3343-3357. JCMM782 [pii];10.1111/j.1582-4934.2009.00782.x [doi].
19. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoshi K, et al. (2008) Sepsis is characterized by the increases in percentages of circulating CD4+ CD25+ regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med 216: 61-68. JST.JSTAGE/tjem/216.61 [pii].
20. Nascimento DC, Alves-Filho JC, Sonego F, Fukada SY, Pereira MS, et al. (2010) Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis. Crit Care Med 38: 1718-1725. 10.1097/CCM.0b013e3181e78ad0 [doi].
21. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, et al. (2004) Increased percentage of CD4+ CD25+ regulatory T cells during septic shock is due to the decrease of CD4+. Crit Care Med 32: 2329-2331. 00003246-200411000-00023 [pii].
22. Buckner JH, (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10: 849-859. nri2889 [pii];10.1038/nri2889 [doi].
23. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, et al. (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19: 345-354. dxm014 [pii];10.1093/intimm/dxm014 [doi].
24. Tran DQ, Ramsey H, Shevach EM, (2007) Induction of FOXP3 expression in naive human CD4+ FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990. blood-2007-06-094656 [pii];10.1182/blood-2007-06-094656 [doi].
25. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500. nri2785 [pii];10.1038/nri2785 [doi].
26. Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, et al. (2012) Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36: 262-275. S1074-7613(12)00040-4 [pii];10.1016/j.immuni.2011.12.012 [doi].
27. Reik W, Dean W, Walter J, (2001) Epigenetic reprogramming in mammalian development. Science 293: 1089-1093. 10.1126/science.1063443 [doi];293/5532/1089 [pii].
28. Raynor J, Lages CS, Shehata H, Hildeman DA, Chougnet CA, (2012) Homeostasis and function of regulatory T cells in aging. Curr Opin Immunol 24: 482-487. S0952-7915(12)00065-9 [pii];10.1016/j.coi.2012.04.005 [doi].
29. Rosenkranz D, Weyer S, Tolosa E, Gaenslen A, Berg D, et al. (2007) Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol 188: 117-127. S0165-5728(07)00174-9 [pii];10.1016/j.jneuroim.2007.05.011 [doi].
30. Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, et al. (2008) Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 181: 1835-1848. 181/3/1835 [pii].
31. Hwang KA, Kim HR, Kang I, (2009) Aging and human CD4(+) regulatory T cells. Mech Ageing Dev 130: 509-517. S0047-6374(09)00084-0 [pii];10.1016/j.mad.2009.06.003 [doi].
32. Santner-Nanan B, Seddiki N, Zhu E, Quent V, Kelleher A, et al. (2008) Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype. Int Immunol 20: 375-383. dxm151 [pii];10.1093/intimm/dxm151 [doi].
33. Liu J, Llui A, Illi S, Layland L, Olek S, et al. (2010) T regulatory cells in cord blood-FOXP3 demethylation as reliable quantitative marker. PLoS One 5: e13267. 10.1371/journal.pone.0013267 [doi].
34. Sehouli J, Loddenkemper C, Cornu T, Schwachula T, Hoffmuller U, et al. (2011) Epigenetic quantification of tumor-infiltrating T-lymphocytes. Epigenetics 6: 236-246. 13755 [pii].
35. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, et al. (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65: 2457-2464. 65/6/2457 [pii];10.1158/0008-5472.CAN-04-3232 [doi].
36. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, et al. (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24: 5373-5380. 24/34/5373 [pii];10.1200/JCO.2006.05.9584 [doi].
37. Hiraki S, Ono S, Tsujimoto H, Kinoshita M, Takahata R, et al. (2012) Neutralization of interleukin-10 or transforming growth factor-beta decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival. Surgery 151: 313-322. S0039-6060(11)00370-9 [pii];10.1016/j.surg.2011.07.019 [doi].
38. Venet F, Guignant C, Monneret G, (2011) Flow cytometry developments and perspectives in clinical studies: examples in ICU patients. Methods Mol Biol 761: 261-275. 10.1007/978-1-61779-182-6_18 [doi].